New lead in the fight against type 1 diabetes

November 20, 2013

Dr. Fraser Scott has been awarded nearly $900,000 from the Canadian Institutes of Health Research (CIHR) to study the possible role of natural anti-microbial proteins in preventing type 1 diabetes. Dr. Scott’s previous research suggests that certain anti-microbial proteins may promote the regeneration of insulin-producing cells in the pancreas, increase levels of “good bacteria” in the gut and promote a protective kind of immune response in animal models, thereby preventing type-1 diabetes.

A summary of this project can be found in CIHR’s Funding Decisions Database.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 x 73325
613-614-5253 (cell)